International Journal of Medical and Oral Research

REVIEW ARTICLE
Year
: 2021  |  Volume : 6  |  Issue : 1  |  Page : 17--21

A comprehensive review on vitiligo and its pharmacotherapy: Recent trends and future challenges


Asmaa Moafa1, Fahad Khalawi2, Nagaraja Sreeharsha3 
1 Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Asha 31982, Saudi Arabia
2 Postgraduate Student, Collage of Pharmacy, Jazan University, Saudi Arabia
3 Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Asha 31982; Professor, Department of Pharmaceutics, Vidya Siri College of Pharmacy, Bengaluru, Karnataka, India, Saudi Arabia

Correspondence Address:
Ms. Asmaa Moafa
Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982
Saudi Arabia

Approximately 1% of population in the world is affected by an intriguing skin depigmentation disorder, vitiligo. Typically, a vitiligo lesions are seen as white milky, nonscaly patches with separate edges. Vitiligo is caused by a selective loss of epidermal melanocytes. In vitiligo, there is impaired melanocyte regeneration and/or multiplication. Although the proportion of the population affected by this disease is very low, the disease is associated with a lot of social stigmas. This defect has an important effect on the life of the patient and still a persistent load.


How to cite this article:
Moafa A, Khalawi F, Sreeharsha N. A comprehensive review on vitiligo and its pharmacotherapy: Recent trends and future challenges.Int J Med Oral Res 2021;6:17-21


How to cite this URL:
Moafa A, Khalawi F, Sreeharsha N. A comprehensive review on vitiligo and its pharmacotherapy: Recent trends and future challenges. Int J Med Oral Res [serial online] 2021 [cited 2022 Jul 6 ];6:17-21
Available from: http://www.ijmorweb.com/article.asp?issn=2772-4883;year=2021;volume=6;issue=1;spage=17;epage=21;aulast=Moafa;type=0